Hrt Financial »

Keros Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $521k 13k 39.70
2022-12-31 $1.0M 21k 48.02

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Linde SHS (LIN)
Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
CRH Ord (CRH)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Align Technology (ALGN)
Spdr S&p 500 Etf Tr Put
Home Depot (HD)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Hrt Financial

Top funds holding Keros Therapeutics

Vanguard Group
OrbiMed Advisors
Braidwell
Darwin Global Management
T. Rowe Price Associates
Candriam Luxembourg S.C.A.
Citadel Advisors
Franklin Resources
ADAR1 Capital Management
Eventide Asset Management
Millennium Management
Deutsche Bank Aktiengesellschaft
Opaleye Management
Blue Owl Capital Holdings
Nantahala Capital Management

View all funds holding Keros Therapeutics